A detailed history of Legal & General Group PLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 272,393 shares of FOLD stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
272,393
Previous 272,393 -0.0%
Holding current value
$2.61 Million
Previous $2.91 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$9.55 - $12.09 $211,370 - $267,587
22,133 Added 8.84%
272,393 $2.91 Million
Q2 2024

Aug 14, 2024

BUY
$9.04 - $11.75 $242,317 - $314,958
26,805 Added 12.0%
250,260 $2.48 Million
Q1 2024

May 14, 2024

BUY
$11.43 - $14.24 $74,237 - $92,488
6,495 Added 2.99%
223,455 $2.63 Million
Q4 2023

Feb 15, 2024

BUY
$9.97 - $14.52 $27,108 - $39,479
2,719 Added 1.27%
216,960 $3.08 Million
Q3 2023

Nov 14, 2023

BUY
$11.78 - $13.86 $49,110 - $57,782
4,169 Added 1.98%
214,241 $2.61 Million
Q2 2023

Aug 14, 2023

SELL
$10.72 - $13.3 $354,403 - $439,698
-33,060 Reduced 13.6%
210,072 $2.64 Million
Q1 2023

May 15, 2023

SELL
$10.91 - $13.54 $1.18 Million - $1.47 Million
-108,499 Reduced 30.86%
243,132 $2.7 Million
Q4 2022

Feb 14, 2023

BUY
$9.89 - $12.7 $308,815 - $396,557
31,225 Added 9.75%
351,631 $4.29 Million
Q3 2022

Nov 14, 2022

BUY
$9.82 - $12.75 $981,607 - $1.27 Million
99,960 Added 45.34%
320,406 $3.35 Million
Q2 2022

Aug 22, 2022

SELL
$6.23 - $11.12 $17,512 - $31,258
-2,811 Reduced 1.26%
220,446 $2.37 Million
Q1 2022

May 16, 2022

BUY
$7.89 - $12.48 $123,762 - $195,761
15,686 Added 7.56%
223,257 $2.11 Million
Q4 2021

Feb 14, 2022

BUY
$9.82 - $12.44 $1,571 - $1,990
160 Added 0.08%
207,571 $2.4 Million
Q3 2021

Nov 15, 2021

BUY
$8.74 - $11.84 $362,290 - $490,791
41,452 Added 24.98%
207,411 $1.98 Million
Q2 2021

Aug 12, 2021

BUY
$8.71 - $10.72 $18,926 - $23,294
2,173 Added 1.33%
165,959 $1.6 Million
Q1 2021

May 17, 2021

BUY
$9.2 - $23.86 $745 - $1,932
81 Added 0.05%
163,786 $1.62 Million
Q4 2020

Feb 12, 2021

BUY
$13.47 - $24.89 $131,884 - $243,697
9,791 Added 6.36%
163,705 $3.78 Million
Q3 2020

Nov 13, 2020

SELL
$12.89 - $15.89 $143,929 - $177,427
-11,166 Reduced 6.76%
153,914 $2.17 Million
Q2 2020

Aug 14, 2020

BUY
$8.86 - $15.69 $94,660 - $167,631
10,684 Added 6.92%
165,080 $2.49 Million
Q1 2020

May 14, 2020

SELL
$6.63 - $11.16 $49,048 - $82,561
-7,398 Reduced 4.57%
154,396 $1.43 Million
Q4 2019

Feb 13, 2020

BUY
$7.48 - $10.75 $231,027 - $332,024
30,886 Added 23.59%
161,794 $1.58 Million
Q3 2019

Nov 13, 2019

BUY
$8.02 - $13.25 $129,651 - $214,199
16,166 Added 14.09%
130,908 $1.05 Million
Q2 2019

Aug 14, 2019

BUY
$10.96 - $14.4 $338,762 - $445,089
30,909 Added 36.87%
114,742 $1.43 Million
Q1 2019

May 15, 2019

BUY
$10.04 - $13.92 $10,019 - $13,892
998 Added 1.2%
83,833 $1.14 Million
Q4 2018

Feb 15, 2019

BUY
$8.38 - $13.44 $136,040 - $218,184
16,234 Added 24.38%
82,835 $793,000
Q2 2018

Aug 10, 2018

SELL
$13.13 - $17.09 $63,404 - $82,527
-4,829 Reduced 6.76%
66,601 $1.04 Million
Q1 2018

May 17, 2018

BUY
$13.76 - $17.12 $20,351 - $25,320
1,479 Added 2.11%
71,430 $1.07 Million
Q4 2017

Feb 13, 2018

BUY
$12.51 - $16.24 $875,087 - $1.14 Million
69,951
69,951 $1.01 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.68B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.